CD27 and neoplasm: Furthermore, the immune-checkpoint gene expression analysis found the low-risk group showed an upregulation of two tumor-necrosis factor co-stimulating factors, CD27 and CD40, both of which are widely expressed in antigen-presenting cells or T/B cells, and have been verified to facilitate tumor cell elimination (Vonderheide, 2020; Wasiuk et al., 2021).